These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 17332083
1. Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research. Shultz LD, Pearson T, King M, Giassi L, Carney L, Gott B, Lyons B, Rossini AA, Greiner DL. Ann N Y Acad Sci; 2007 Apr; 1103():77-89. PubMed ID: 17332083 [Abstract] [Full Text] [Related]
2. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson MA, Wasserfall C, Herold KC, Woodland RT, Schmidt MR, Woda BA, Thompson MJ, Rossini AA, Greiner DL. Clin Immunol; 2008 Mar; 126(3):303-14. PubMed ID: 18096436 [Abstract] [Full Text] [Related]
3. Development of new-generation HU-PBMC-NOD/SCID mice to study human islet alloreactivity. King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson M, Wasserfall C, Herold K, Mordes JP, Rossini AA, Greiner DL. Ann N Y Acad Sci; 2007 Apr; 1103():90-3. PubMed ID: 17376822 [Abstract] [Full Text] [Related]
4. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model. Zhao Y, Guo C, Hwang D, Lin B, Dingeldein M, Mihailescu D, Sam S, Sidhwani S, Zhang Y, Jain S, Skidgel RA, Prabhakar BS, Mazzone T, Holterman MJ. Biochem Biophys Res Commun; 2010 Sep 03; 399(4):629-36. PubMed ID: 20691153 [Abstract] [Full Text] [Related]
5. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo. Ito A, Ishida T, Utsunomiya A, Sato F, Mori F, Yano H, Inagaki A, Suzuki S, Takino H, Ri M, Kusumoto S, Komatsu H, Iida S, Inagaki H, Ueda R. J Immunol; 2009 Oct 01; 183(7):4782-91. PubMed ID: 19748990 [Abstract] [Full Text] [Related]
6. E2F-1-deficient NOD/SCID mice developed showing decreased saliva production. Matsui-Inohara H, Uematsu H, Narita T, Satoh K, Yonezawa H, Kuroda K, Ito T, Yoneda S, Kawarai T, Sugiya H, Watanabe H, Senpuku H. Exp Biol Med (Maywood); 2009 Dec 01; 234(12):1525-36. PubMed ID: 19934373 [Abstract] [Full Text] [Related]
7. Viral infections as potential triggers of type 1 diabetes. van der Werf N, Kroese FG, Rozing J, Hillebrands JL. Diabetes Metab Res Rev; 2007 Mar 01; 23(3):169-83. PubMed ID: 17103489 [Abstract] [Full Text] [Related]
8. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes. Serreze DV, Marron MP, Dilorenzo TP. Ann N Y Acad Sci; 2007 Apr 01; 1103():103-11. PubMed ID: 17376821 [Abstract] [Full Text] [Related]
9. Type 1 diabetes genes and pathways shared by humans and NOD mice. Wicker LS, Clark J, Fraser HI, Garner VE, Gonzalez-Munoz A, Healy B, Howlett S, Hunter K, Rainbow D, Rosa RL, Smink LJ, Todd JA, Peterson LB. J Autoimmun; 2005 Apr 01; 25 Suppl():29-33. PubMed ID: 16257508 [Abstract] [Full Text] [Related]
10. Lessons on autoimmune diabetes from animal models. Yang Y, Santamaria P. Clin Sci (Lond); 2006 Jun 01; 110(6):627-39. PubMed ID: 16689681 [Abstract] [Full Text] [Related]
11. Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth. Roep BO. Ann N Y Acad Sci; 2007 Apr 01; 1103():1-10. PubMed ID: 17376838 [Abstract] [Full Text] [Related]
12. Interleukin 12 and autoimmune diabetes. Adorini L. Nat Genet; 2001 Feb 01; 27(2):131-2. PubMed ID: 11175771 [Abstract] [Full Text] [Related]
13. Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse. Giarratana N, Penna G, Adorini L. Methods Mol Biol; 2007 Feb 01; 380():285-311. PubMed ID: 17876100 [Abstract] [Full Text] [Related]
14. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice. Ito R, Katano I, Kawai K, Hirata H, Ogura T, Kamisako T, Eto T, Ito M. Transplantation; 2009 Jun 15; 87(11):1654-8. PubMed ID: 19502956 [Abstract] [Full Text] [Related]
15. The crucial role of IL-2/IL-2RA-mediated immune regulation in the pathogenesis of type 1 diabetes, an evidence coming from genetic and animal model studies. Chistiakov DA, Voronova NV, Chistiakov PA. Immunol Lett; 2008 Jun 15; 118(1):1-5. PubMed ID: 18417224 [Abstract] [Full Text] [Related]
16. A comprehensive review of interventions in the NOD mouse and implications for translation. Shoda LK, Young DL, Ramanujan S, Whiting CC, Atkinson MA, Bluestone JA, Eisenbarth GS, Mathis D, Rossini AA, Campbell SE, Kahn R, Kreuwel HT. Immunity; 2005 Aug 15; 23(2):115-26. PubMed ID: 16111631 [Abstract] [Full Text] [Related]
17. Establishment and characterization of in vivo human tumor models in the NOD/SCID/gamma(c)(null) mouse. Fujii E, Suzuki M, Matsubara K, Watanabe M, Chen YJ, Adachi K, Ohnishi Y, Tanigawa M, Tsuchiya M, Tamaoki N. Pathol Int; 2008 Sep 15; 58(9):559-67. PubMed ID: 18801070 [Abstract] [Full Text] [Related]
18. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice. Kuruvilla JG, Troyer RM, Devi S, Akkina R. Virology; 2007 Dec 05; 369(1):143-52. PubMed ID: 17707071 [Abstract] [Full Text] [Related]
19. Prominently decreased hippocampal neurogenesis in a spontaneous model of type 1 diabetes, the nonobese diabetic mouse. Beauquis J, Saravia F, Coulaud J, Roig P, Dardenne M, Homo-Delarche F, De Nicola A. Exp Neurol; 2008 Apr 05; 210(2):359-67. PubMed ID: 18190910 [Abstract] [Full Text] [Related]
20. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice. Xia CQ, Peng R, Qiu Y, Annamalai M, Gordon D, Clare-Salzler MJ. Diabetes; 2007 Aug 05; 56(8):2116-23. PubMed ID: 17496235 [Abstract] [Full Text] [Related] Page: [Next] [New Search]